Literature DB >> 8795382

Fibrinolysis of experimental subretinal haemorrhage without removal using tissue plasminogen activator.

L S Morse1, J D Benner, L M Hjelmeland, M B Landers.   

Abstract

AIMS/
BACKGROUND: Human recombinant tissue plasminogen activator (rt-PA) fibrinolysis of subretinal haemorrhage with concomitant removal has been shown to reverse the natural history of photoreceptor degeneration in experimental subretinal haemorrhages if evacuated within 7 days. The aim of the study was to determine whether fibrinolysis of subretinal haemorrhage without concomitant removal would offer a simpler approach with similar photoreceptor sparing.
METHODS: A neodymium YAG laser was used to create experimental subretinal haemorrhages beneath the holangiotic retina of the cat. Tissue plasminogen activator (10 micrograms/ml) was injected into 4 day old subretinal haemorrhages to evaluate its effect on altering the natural history of retinal degeneration. Light and electron microscopy were used to study the histopathological effect.
RESULTS: The injection of rt-PA into large 4 day old subretinal haemorrhages without concomitant removal did not alter the natural history of retinal degeneration. In fact, a second focus of retinal degeneration occurred at a gravity dependent inferior site where the subretinal haemorrhages had migrated.
CONCLUSIONS: There was no therapeutic benefit from the injection of rt-PA into subretinal haemorrhages without con-comitant removal in this cat model.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8795382      PMCID: PMC505564          DOI: 10.1136/bjo.80.7.658

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  20 in total

1.  Subretinal endolaser treatment of a choroidal bleeding site.

Authors:  M A Thomas; L S Halperin
Journal:  Am J Ophthalmol       Date:  1990-06-15       Impact factor: 5.258

2.  Applications of a cannulated extrusion needle during vitreoretinal microsurgery.

Authors:  H W Flynn; J L Davis; J M Parel; W G Lee
Journal:  Retina       Date:  1988       Impact factor: 4.256

3.  Early surgical drainage of macular subretinal hemorrhage.

Authors:  T A Hanscom; K R Diddie
Journal:  Arch Ophthalmol       Date:  1987-12

4.  Morphological recovery in the reattached retina.

Authors:  D H Anderson; C J Guérin; P A Erickson; W H Stern; S K Fisher
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-02       Impact factor: 4.799

5.  Effect of intravitreal tissue plasminogen activator on experimental subretinal hemorrhage.

Authors:  G E Coll; J R Sparrow; A Marinovic; S Chang
Journal:  Retina       Date:  1995       Impact factor: 4.256

6.  [Ultrastructural studies on absorption of an experimentally produced subretinal hemorrhage. III. Absorption of erythrocyte break down products and retinal hemosiderosis at the late stage (author's transl)].

Authors:  A Koshibu
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1979-05-10

7.  Management of traumatic hemorrhagic retinal detachment with pars plana vitrectomy.

Authors:  D P Han; W F Mieler; D M Schwartz; G W Abrams
Journal:  Arch Ophthalmol       Date:  1990-09

8.  Factors prognostic of visual outcome in patients with subretinal hemorrhage.

Authors:  S R Bennett; J C Folk; C F Blodi; M Klugman
Journal:  Am J Ophthalmol       Date:  1990-01-15       Impact factor: 5.258

9.  Absorption of retinal and subretinal hemorrhages.

Authors:  A Gillies; M Lahav
Journal:  Ann Ophthalmol       Date:  1983-11

10.  Subretinal hemorrhage management by pars plana vitrectomy and internal drainage.

Authors:  E C Wade; H W Flynn; K R Olsen; M S Blumenkranz; D H Nicholson
Journal:  Arch Ophthalmol       Date:  1990-07
View more
  1 in total

1.  Combined Administration of Preoperative Intravitreal and Intraoperative Subretinal Recombinant Tissue Plasminogen Activator in Acute Hemorrhagic Age-related Macular Degeneration.

Authors:  Khaled Helaiwa; Lina R Paez; Peter Szurman; Kai Januschowski
Journal:  Cureus       Date:  2020-03-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.